143 related articles for article (PubMed ID: 29334312)
21. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
22. XPO1 is a new target of homoharringtonine (HHT): Making NPMc
Xue J; Chu P; Gao W; Wang F; Gao Y; Liu S; Kang Z; Yan J; Wang H
Biochem Biophys Res Commun; 2023 Oct; 675():155-161. PubMed ID: 37473530
[TBL] [Abstract][Full Text] [Related]
23. Bcl-xL is a dominant antiapoptotic protein that inhibits homoharringtonine-induced apoptosis in leukemia cells.
Yin S; Wang R; Zhou F; Zhang H; Jing Y
Mol Pharmacol; 2011 Jun; 79(6):1072-83. PubMed ID: 21415308
[TBL] [Abstract][Full Text] [Related]
24. Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC.
Li C; Dong L; Su R; Bi Y; Qing Y; Deng X; Zhou Y; Hu C; Yu M; Huang H; Jiang X; Li X; He X; Zou D; Shen C; Han L; Sun M; Skibbe J; Ferchen K; Qin X; Weng H; Huang H; Song C; Chen J; Jin J
Haematologica; 2020 Jan; 105(1):148-160. PubMed ID: 30975912
[TBL] [Abstract][Full Text] [Related]
25. The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia.
Shi Y; Ye J; Yang Y; Zhao Y; Shen H; Ye X; Xie W
Front Oncol; 2021; 11():692497. PubMed ID: 34336680
[TBL] [Abstract][Full Text] [Related]
26. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
Kosciuczuk EM; Saleiro D; Platanias LC
Cytokine; 2017 Jan; 89():116-121. PubMed ID: 27094611
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
28. The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.
Li X; Yin X; Wang H; Huang J; Yu M; Ma Z; Li C; Zhou Y; Yan X; Huang S; Jin J
Oncotarget; 2017 Feb; 8(8):12764-12774. PubMed ID: 28061447
[TBL] [Abstract][Full Text] [Related]
29. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways.
Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y
Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078
[TBL] [Abstract][Full Text] [Related]
30. [Overexpression of eIF4E gene in acute myeloid leukemia and its relation with disease progression].
Jiang YD; Lu YH; Chen SH; Zhu KE; Zhang XL; Yu Z; Zhong J; Zhang T; Luo GX; Chen J; Pan HY; Li Y; Qin LA; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):296-9. PubMed ID: 23628019
[TBL] [Abstract][Full Text] [Related]
31. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
[TBL] [Abstract][Full Text] [Related]
32. Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia.
Chen X; Tang Y; Chen J; Chen R; Gu L; Xue H; Pan C; Tang J; Shen S
Front Med; 2019 Jun; 13(3):378-387. PubMed ID: 30635781
[TBL] [Abstract][Full Text] [Related]
33. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Homoharringtonine for the Treatment of Acute Myeloid Leukemia: A Meta-analysis.
Mi R; Zhao J; Chen L; Wei X; Liu J; Wei X
Clin Lymphoma Myeloma Leuk; 2021 Oct; 21(10):e752-e767. PubMed ID: 34301487
[TBL] [Abstract][Full Text] [Related]
35. Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.
Shi Y; Xu D; Xu Y; Shen H; Zhang Y; Ye X; Jin J; Cui D; Xie W
J Oncol; 2022; 2022():9005804. PubMed ID: 36081666
[TBL] [Abstract][Full Text] [Related]
36. Synergistic cytotoxicity of homoharringtonine and etoposide in acute myeloid leukemia cells involves disrupted antioxidant defense.
Zhang J; Geng H; Liu L; Zhang H
Cancer Manag Res; 2019; 11():1023-1032. PubMed ID: 30774430
[TBL] [Abstract][Full Text] [Related]
37. Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms.
Nguyen T; Parker R; Zhang Y; Hawkins E; Kmieciak M; Craun W; Grant S
BMC Cancer; 2018 Nov; 18(1):1129. PubMed ID: 30445933
[TBL] [Abstract][Full Text] [Related]
38. [Combination of Homoharringtonine with Arsenic Trioxide Induces Apoptosis of Human Acute Myeloid Leukemia Cell Line U937].
Chen P; Jiang X; You PD; Jin Q; Yuan Q; Huang HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1649-1653. PubMed ID: 28024471
[TBL] [Abstract][Full Text] [Related]
39. [Cytotoxicity of homoharringtonine on leukemic stem-like cells in AML cell line KG-1].
Shen JP; Yang H; Ni WM; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):485-90. PubMed ID: 23086639
[TBL] [Abstract][Full Text] [Related]
40. The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.
Osborne MJ; Borden KL
Immunol Rev; 2015 Jan; 263(1):210-23. PubMed ID: 25510279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
